Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report
<i>Background and Objectives</i>: Caesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy in which the early pregnancy implants at the site of the uterine scar. Methotrexate (MTX) in lower doses can be used to treat CSPs. However, MTX administration is associated with a spectr...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/11/1900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846153042379931648 |
|---|---|
| author | Sofoklis Stavros Anastasios Potiris Angeliki Gerede Athanasios Zikopoulos Maria Giourga Christina Karasmani Athanasios Karpouzos Theodoros Karampitsakos Spyridon Topis Ismini Anagnostaki Konstantinos Louis Ioannis Tsakiridis Themistoklis Dagklis Peter Drakakis Ekaterini Domali |
| author_facet | Sofoklis Stavros Anastasios Potiris Angeliki Gerede Athanasios Zikopoulos Maria Giourga Christina Karasmani Athanasios Karpouzos Theodoros Karampitsakos Spyridon Topis Ismini Anagnostaki Konstantinos Louis Ioannis Tsakiridis Themistoklis Dagklis Peter Drakakis Ekaterini Domali |
| author_sort | Sofoklis Stavros |
| collection | DOAJ |
| description | <i>Background and Objectives</i>: Caesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy in which the early pregnancy implants at the site of the uterine scar. Methotrexate (MTX) in lower doses can be used to treat CSPs. However, MTX administration is associated with a spectrum of side effects that include hematological toxicities. This case report presents a CSP treated with an intragestational injection of MTX and subsequently developed pancytopenia. <i>Materials and Methods</i>: A 23-year-old woman at six weeks and six days of pregnancy was referred as a potential case of CSP. After establishing the diagnosis, she was treated with a transvaginal ultrasound-guided intragestational administration of 80 mg MTX (adjusted to 50 mg/m<sup>2</sup> body surface area) under sedation. <i>Results</i>: On day four after the MTX injection, she developed oral ulcers, fever, and pruritic phlyctenular maculopapular rash. Subsequently, the patient developed febrile neutropenia and was admitted to the Intensive Care Unit. On day six, a subsequent exacerbation of the rash was observed with the formation of blisters and purplish spots with concurrent odynophagia and sialorrhea. Ultimately, the patient developed pancytopenia due to bone marrow suppression. Fifteen days after MTX administration, the patient recovered and was discharged from the hospital hemodynamically stable, afebrile, with dropping β-hcg levels, and in good clinical condition. <i>Conclusions</i>: Although methotrexate administration is the preferred option for the treatment of cesarean scar pregnancies, clinicians should be aware of the fact that its use entails potential risks, even when it is used locally. To our knowledge, this case is the first description of pancytopenia due to bone marrow suppression following a single low dose of intragestational methotrexate injection. |
| format | Article |
| id | doaj-art-f33646f1ce1c4e2e899eabc3f80b5036 |
| institution | Kabale University |
| issn | 1010-660X 1648-9144 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj-art-f33646f1ce1c4e2e899eabc3f80b50362024-11-26T18:12:53ZengMDPI AGMedicina1010-660X1648-91442024-11-016011190010.3390/medicina60111900Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case ReportSofoklis Stavros0Anastasios Potiris1Angeliki Gerede2Athanasios Zikopoulos3Maria Giourga4Christina Karasmani5Athanasios Karpouzos6Theodoros Karampitsakos7Spyridon Topis8Ismini Anagnostaki9Konstantinos Louis10Ioannis Tsakiridis11Themistoklis Dagklis12Peter Drakakis13Ekaterini Domali14Third Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceDepartment of Obstetrics and Gynecology, Democritus University of Thrace, 691 00 Campus, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceFirst Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, GreeceFirst Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, GreeceFirst Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceThird Department of Obstetrics and Gynecology, General Hospital Ippokratio, Medical School, Aristotle University of Thessaloniki, 546 42 Thessaloniki, GreeceThird Department of Obstetrics and Gynecology, General Hospital Ippokratio, Medical School, Aristotle University of Thessaloniki, 546 42 Thessaloniki, GreeceThird Department of Obstetrics and Gynecology, University General Hospital “ATTIKON”, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, GreeceFirst Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, 115 28 Athens, Greece<i>Background and Objectives</i>: Caesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy in which the early pregnancy implants at the site of the uterine scar. Methotrexate (MTX) in lower doses can be used to treat CSPs. However, MTX administration is associated with a spectrum of side effects that include hematological toxicities. This case report presents a CSP treated with an intragestational injection of MTX and subsequently developed pancytopenia. <i>Materials and Methods</i>: A 23-year-old woman at six weeks and six days of pregnancy was referred as a potential case of CSP. After establishing the diagnosis, she was treated with a transvaginal ultrasound-guided intragestational administration of 80 mg MTX (adjusted to 50 mg/m<sup>2</sup> body surface area) under sedation. <i>Results</i>: On day four after the MTX injection, she developed oral ulcers, fever, and pruritic phlyctenular maculopapular rash. Subsequently, the patient developed febrile neutropenia and was admitted to the Intensive Care Unit. On day six, a subsequent exacerbation of the rash was observed with the formation of blisters and purplish spots with concurrent odynophagia and sialorrhea. Ultimately, the patient developed pancytopenia due to bone marrow suppression. Fifteen days after MTX administration, the patient recovered and was discharged from the hospital hemodynamically stable, afebrile, with dropping β-hcg levels, and in good clinical condition. <i>Conclusions</i>: Although methotrexate administration is the preferred option for the treatment of cesarean scar pregnancies, clinicians should be aware of the fact that its use entails potential risks, even when it is used locally. To our knowledge, this case is the first description of pancytopenia due to bone marrow suppression following a single low dose of intragestational methotrexate injection.https://www.mdpi.com/1648-9144/60/11/1900ectopic pregnancycesarean scar pregnancymethotrexateearly pregnancypancytopeniaintragestational injection |
| spellingShingle | Sofoklis Stavros Anastasios Potiris Angeliki Gerede Athanasios Zikopoulos Maria Giourga Christina Karasmani Athanasios Karpouzos Theodoros Karampitsakos Spyridon Topis Ismini Anagnostaki Konstantinos Louis Ioannis Tsakiridis Themistoklis Dagklis Peter Drakakis Ekaterini Domali Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report Medicina ectopic pregnancy cesarean scar pregnancy methotrexate early pregnancy pancytopenia intragestational injection |
| title | Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report |
| title_full | Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report |
| title_fullStr | Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report |
| title_full_unstemmed | Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report |
| title_short | Methotrexate-Induced Toxicity After Ultrasound-Guided Intragestational Injection in a Patient with Caesarean Scar Pregnancy—A Case Report |
| title_sort | methotrexate induced toxicity after ultrasound guided intragestational injection in a patient with caesarean scar pregnancy a case report |
| topic | ectopic pregnancy cesarean scar pregnancy methotrexate early pregnancy pancytopenia intragestational injection |
| url | https://www.mdpi.com/1648-9144/60/11/1900 |
| work_keys_str_mv | AT sofoklisstavros methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT anastasiospotiris methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT angelikigerede methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT athanasioszikopoulos methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT mariagiourga methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT christinakarasmani methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT athanasioskarpouzos methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT theodoroskarampitsakos methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT spyridontopis methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT isminianagnostaki methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT konstantinoslouis methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT ioannistsakiridis methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT themistoklisdagklis methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT peterdrakakis methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport AT ekaterinidomali methotrexateinducedtoxicityafterultrasoundguidedintragestationalinjectioninapatientwithcaesareanscarpregnancyacasereport |